With a shared purpose, we can realize the true promise of CRISPR and improve healthcare, providing hope to more patients with ...

Nobel laureate Jennifer Doudna, PhD; Matthew Porteus, MD, PhD, and Rodolphe Barrangou, PhD—offer their views on the commercial potential and challenges of genome editing following a rollercoaster 2025 ...

However, there are certain things AI can't do -- and may never be able to do. One of them is to cure diseases. Biotech companies that develop and market breakthrough therapies for, thus far, ...

Vertex executives warned that Casgevy, its curative treatment for sickle cell disease, would be slow to reach patients. But ...

Researchers reprogrammed bacterial bridge recombinases to edit large genomic regions in mammalian cells, revealing a ...

When it was announced in 2023 that the world’s first Crispr-based gene-editing therapy had been approved in the UK there was ...

A new technique brings CRISPR-mediated gene editing together with spatial transcriptomics and imaging to study the ...

Oceanic ecosystems are increasingly threatened by global warming, which causes coral bleaching, species migration and, ...

CRISPR-Cas9 genome editing enzyme. [Artur Plawgo / iStock / Getty Images Plus] We need a patient-first approach for any variant in any patient, whomever, wherever they are. Each and every patient ...

Muscles make up nearly 40% of the human body and power every move we make, from a child's first steps to recovery after ...